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Abstract
The role of the subthalamic nucleus in human locomotion is unclear although relevant, given
the troublesome management of gait disturbances with subthalamic deep brain stimulation
in patients with Parkinson’s disease. We investigated the subthalamic activity and inter-
hemispheric connectivity during walking in eight freely-moving subjects with Parkinson’s dis-
ease and bilateral deep brain stimulation. In particular, we compared the subthalamic power
spectral densities and coherence, amplitude cross-correlation and phase locking value
between resting state, upright standing, and steady forward walking. We observed a phase
locking value drop in the β-frequency band (13-35Hz) during walking with respect to rest-
ing and standing. This modulation was not accompanied by specific changes in subthalamic
power spectral densities, which was not related to gait phases or to striatal dopamine loss
measured with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane and
single-photon computed tomography. We speculate that the subthalamic inter-hemispheric
desynchronization in the β-frequency band reflects the information processing of each body
side separately, which may support linear walking. This study also suggests that in some
cases (i.e. gait) the brain signal, which could allow feedback-controlled stimulation, might
derive from network activity.
Introduction
Human gait is a complex motor behavior and requires a constant and coordinated flow of
information across functionally specialized brain areas [1]. The locomotor network can be
schematically divided into a spinal and a supraspinal component comprising of different corti-
cal areas (including the supplementary motor area, SMA), the basal ganglia, the subthalamic
nucleus (STN), the mesencephalic locomotor region (MLR), and the cerebellum [1–4]. At a
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spinal level, a central pattern generator (CPG) can produce the basic motor pattern for step-
ping (rhythmic motor activity) autonomously, in the absence of supraspinal and sensory
inputs[5]. The selection and modulation of gaits (e.g. initiation, termination, velocity, direc-
tion, and spatial orientation) are instead performed at the higher levels of the nervous system
[6,7].
Locomotion is controlled by the tuned interplay of such neural circuits and can be studied
by assessing their oscillatory activity [8,9]. In particular, the phase synchronization between
oscillatory neural circuits is hypothesized to facilitate the efficacy of information exchange
between different brain areas and could be particularly relevant for an efficient flow of infor-
mation in large-scale networks, such as the locomotor network [9–13].
In this framework, the role of the basal ganglia is poorly defined but their involvement in
locomotion is clearly suggested by the presence of gait impairment in neurological diseases
with altered basal ganglia functioning, such as Parkinson’s disease (PD) [14]. In particular, the
STN is an essential node of the supraspinal locomotor network, being connected to the SMA
and projecting to the MLR directly and through the basal ganglia output nuclei (i.e. the globus
pallidus pars interna [GPi] and the substantia nigra pars reticulate [SNr]) [15]. The STN is
active during gait [4], and the modulation of its activity with deep brain stimulation
(STN-DBS) impacts gait performances [16].
In PD, the loss of striatal dopaminergic innervation determines an excessive synchroniza-
tion of subcortical neuronal oscillations to cortical rhythm, thus hindering subcortical motor
control processing [17–21]. These functional derangements are usually observed in the STN.
Local field potentials (LFPs) recorded in unmedicated PD patients showed an excessive syn-
chronization of the STN neuronal oscillations in the β-frequency band (13–35 Hz), which
extends to connected nuclei (e.g. the GPi and motor cortices) and to the opposite hemisphere
[19,22–25]. Such synchronization correlates with the severity of parkinsonian symptoms, and
diminishes with dopaminergic medications, deep brain stimulation (DBS) and during move-
ment preparation and execution [26].
Published works have focused on the use of β-band activity as a control signal for closed-
loop DBS in patients with PD [27,28]. Pursuant to such study, extensive neurophysiological
work will be required to describe not only symptom-specific physiomarkers [18,20,22], but
especially physiological markers of particular brain states (e.g. gait and sleep) [29]. To this end,
under the hypothesis of a direct involvement of the STN during fine-tuning of complex and
synchronized bilateral movements [19,30,31], we investigated the subthalamic local neuronal
oscillations and inter-hemispheric coupling during gait. We also established whether STN
oscillatory changes were related to specific phases of gait, assessed with a kinematic analysis,
and influenced by striatal dopaminergic loss, measured with [123I]N-ω-fluoropropyl-2β-carbo-
methoxy-3β-(4-iodophenyl)nortropane (FP-CIT) and single-photon computed tomography
(SPECT).
Methods
Patients and surgery
We enrolled eight subjects with PD implanted at Julius-Maximilians-University-Hospital
Wuerzburg between December 2013 and May 2014 with the Activa PC+S1 neurostimulation
system (Medtronic, PLC). This system allows therapeutic DBS as well as on-demand recording
of the LFPs from the implanted electrodes [32,33]. The Activa PC+S1 system and the related
hard- and software for programming and readout were provided under a request for applica-
tion agreement with Medtronic, PLC. The company was not involved in study design, patient
selection, data analysis, or reporting of the results.
Subcortical control of locomotion
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All patients were diagnosed with PD according to the UK Parkinson Disease Brain Bank
criteria [34] and met the inclusion criteria for bilateral STN-DBS [35]. None of them had cog-
nitive decline or mood disturbances as evaluated with standardized rating scales (i.e. Parkin-
son neuropsychometric dementia assessment, Mattis dementia rating scale, Hamilton
depression rating scale and the non-motor symptoms scale). For clinical assessment, patients
were evaluated within one month before surgery (pre-DBS) with the United Parkinson’s Dis-
ease Rating Scales motor score (UPDRS-III) after overnight (>12 h) withdrawal of all dopami-
nergic medications (meds-off) and upon receiving 1 to 1.5-times (range 200/50-300/75 mg of
levodopa/benserazide) the levodopa-equivalent of the morning dose (meds-on) [36]. After sur-
gery (post-DBS), patients were assessed with the UPDRS-III in four conditions: (i) stimulation
off for at least two hours (stim-off); (ii) with bilateral STN stimulation (stim-on) [monopolar
stimulation (6/7 subjects); mean amplitude: 3.1 mA (SD: 0.76 mA); pulse width 60 μs; mean
frequency 138 Hz (SD 31 Hz)]; (iii) meds-on (as before surgery); (iv) meds-on and stim-on.
The therapeutic response to DBS or levodopa was expressed as percentage of improvement
according to the formula, adapted from Isaias and coll. [37]:
ða   bÞ=a x100 ð1Þ
where (a) is meds-off UPDRS-III score and (b) is meds-on UPDRS-III score at pre-DBS or
meds-off, stim-on UPDRS-III score at the time of the study. In this study, all subjects were
tested at least six months after surgery. At the time of the experiment, all patients were on sta-
ble dopaminergic treatment (for at least two months) and chronically stimulated (at least one
month with unchanged DBS parameters). The Institutional Review Board of the University
Hospital Wuerzburg approved the study and all patients gave written informed consent. The
applied methods were conducted in accordance with the Declaration of Helsinki.
The surgical procedure has been previously described [38]. In brief, implantation was per-
formed under local anesthesia using Leksell’s Frame (Elekta, Leksell Stereotaxy System, Stock-
holm, Sweden). The DBS electrode used was model 3389 (Medtronic, PLC) with four platinum–
iridium cylindrical contacts of 1.5 mm each and a contact-to-contact separation of 0.5 mm. Con-
tacts 0 and 8 were the lowermost and contacts 3 and 11 the uppermost (E0-3 refers to right- and
E8-11 to the left-hemisphere). The intended coordinates for STN were 12 mm lateral, 2 mm pos-
terior, 4 mm ventral to the mid-commissural point and were adjusted according to individual
STN delineation on T2-weighted and SWI images (MAGNETOM Trio, SIEMENS Healthcare,
Erlangen, Germany) and with intraoperative microelectrode recordings. Micro- and macro-elec-
trode stimulation and intraoperative CT scan also served to confirm targeting. Postoperative
scanning (1 mm slice-thickness CT scan fusion with the pre-operative MRI) confirmed the elec-
trode location. The precise localization within the STN of the active contacts used for chronic
stimulation was further confirmed by means of SureTuneTM (Medtronic, PLC) [39].
Protocol, set-up and biomechanical data processing
Recordings were performed at the gait laboratory of the Department of Neurology, University
Hospital Wuerzburg. Patients were investigated in the morning at least 12 h after their last
dose of antiparkinsonian medication and at two hours after pausing the stimulation. Patients
performed at least three trials (range 3–7) according to their clinical conditions for an assess-
ment program involving three conditions: (i) resting (i.e. quietly sitting for 60 s with eyes open
during random thinking); (ii) upright standing (for 60 s); (iii) over-ground bare-foot walking
at self-selected speed.
For the biomechanical analysis, we considered the steps performed at steady state velocity
(steady state linear walking) in a calibrated volume of 8 x 2 x 5 m (total number of 227 strides,
Subcortical control of locomotion
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range: 19–37 strides per patient). Kinematics of body segments was measured using an
optoelectronic system (SMART-DX400, BTS, Milano, Italy), which computed the 3D coordi-
nates of 29 spherical retro-reflective markers (15 mm diameter) fixed to anatomical landmarks
[40,41]. The marker coordinates were low-pass filtered (cut-off frequency of 7 Hz) and inter-
polated. Kinematic parameters were automatically extracted by ad hoc algorithms developed
in Matlab1 ambient (Matlab 2015b, The MathWorks, Inc., Natick, Massachusetts, USA) and
then checked by visual inspection. Steady state linear walking was described by spatio-tempo-
ral gait parameters: stride length, duration, and velocity (normalized to subject’s height),
stance and double-support duration. Temporal parameters (i.e. stance and double-support)
were time-normalized as a percentage of the stride duration. For each subject and condition,
all variables have been averaged over the trials. With the same experimental setup, we also eval-
uated 11 healthy controls (9 males, 2 females; median age 60 years, range 50–66 years) matched
for age and anthropometric measurements.
Differences in spatio-temporal gait parameters between controls and PD groups were ana-
lyzed with Steel-Dwass all pairs test. We used JMP software version 13 (SAS Institute Inc.,
Cary, North Carolina, USA).
SPECT imaging
SPECT data acquisition and reconstruction has been previously described [42,43]. All
patients performed a SPECT with FP-CIT to measure the dopamine reuptake transporter
(DAT) density within three months before surgery (in the best medical and DBS treatment
state). Scans were started 180 min after injection of 182.4±3.6 MBq of FP-CIT on a dual-
headed integrated SPECT/CT system (Symbia T2; Siemens, Erlangen, Germany). SPECT
data were spatially normalized onto a FP-CIT MNI-based template and volumes of interest
(i.e. left and right caudate nucleus, left and right putamen, left and right striatum) as well as
a reference region in the occipital cortex were defined using the volume of interest (VOI) of
the automated anatomical labeling method [44]. The non-displaceable binding potential
(BPND) for caudate nucleus, putamen and whole striatum (for both hemispheres) was then
assessed using average regional uptake values from VOI analysis and the occipital cortex as
reference region [45]. Based on molecular imaging data, we identified the hemisphere with
less (STN–) or more (STN+) dopaminergic innervation. We used the whole striatum, rather
than its motor part (i.e. the putamen), as the boundaries between the putamen and the cau-
date nucleus are uncertain in SPECT images. Asymmetry indexes (AI) for striatal BPND
were calculated using the formula:
ðBPNDstriatum ipsilateral   BPNDstriatum contralateralÞ
ðBPNDstriatum ipsilateral þ BPNDstriatum contralateralÞ
x 200 ð2Þ
Contralateral refers in this case to the striatum opposite to the clinically most affected side.
For healthy subjects, we conventionally refer to the right side as ipsilateral [46,47]. Striatal
DAT binding measurements of the patient group were compared with normal values of 15
healthy subjects (4 males, 11 females; median age 67 years, range 44–74). The Institutional
Review Board of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano
approved the investigation, which was conducted in accordance with the Declaration of Hel-
sinki, and all patients gave written informed consent.
Differences in BPND of DAT between controls and PD groups were analyzed with the Steel-
Dwass all pairs test. We used JMP software version 13 (SAS Institute Inc., Car, North Carolina,
USA).
Subcortical control of locomotion
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LFPs recordings and synchronization
We recorded subthalamic LFPs with a single bipolar derivation for each STN, amplified by
2000 and sampled at 422 Hz. The recording contacts were selected accordingly to clinical effect
of chronic stimulation: we selected a bipolar montage crossing the chronically active electrode
[48].
A limitation of the Activa PC+S1 system is the recording of the ECG artefact by the ventral
contacts [49]. We removed ECG waves in LFP recordings of three out of 14 STNs by detecting
the signal peaks representing QRS complexes. Details about the ECG correction algorithms
and relevant discussion can be found in [19].
Synchronicity across STN recordings and kinematic measures has been previously
described [19]. In brief, synchronization was achieved by means of a transcutaneous electrical
nerve stimulation (TENS) artefact that was introduced on-demand into the acquisition sys-
tems. The electrodes for the TENS were placed in the supraclavicular fossa, directly on the
cable that connects the impulse generator with the electrodes, and over the burr-hole site. The
same TENS artefact fed into the Activa PC+S1 and the SMART-DX400. We introduced two
TENS artefacts: one at the beginning and one at the end of each recording session, thus
accounting for the different nominal and real sampling frequencies of the acquisition systems.
We detected the TENS artefact in all recordings and used the sharp drop-off as synchroniza-
tion instant across modalities. After synchronization, the analyses were further performed
with the dataset containing LFPs resampled at 400 Hz, excluding the time windows with the
TENS artefacts.
Power spectral analyses
We characterized the STN power modulation of resting, upright standing and walking by
means of the multi tapers method (five tapers) [50]. Given the relative novelty of the Activa PC
+S1 system, we first defined the quality of the acquired signal with respect to the internal
noise. Manufacturer datasheet as well as previous publications reported a nominal noise floor
(NF) for the beta band of 150nV/rtHz [32,33]. We normalized the PSD dividing by the square
of NF and transformed it into dB/Hz (10Log10(PSD/NF^2)). After this conversion, 0dB/Hz
corresponds to the minimum threshold for reliability (Fig 1). We then estimated group level
variance using the bootstrapping (20 repetitions; resampling with replacement) technique and
estimated the confidence intervals between 5th and 95th percentiles of the bootstrap
distributions.
We then analyzed the STN activity within the gait phases. We used the wavelet transform
with 60 Morlet wavelets with 10 cycles/s (from 6 to 90 Hz) [51]. Frequencies below 6 Hz were
discarded as the selected time resolution of 10 cycles/s exceeds the stride duration. This
allowed exclusion of low-frequency biological artefacts. We calculated the event-related power
relative changes (event related synchronization [ERS] and desynchronization [ERD]), normal-
izing the mean low-β, high-β and γ power by subtracting and dividing for the average of the
entire recording (baseline), to reduce the effects of single-trial normalization:
ðX   BaselineÞ=Baseline ð3Þ
Since stride length varied across subjects, we normalized the ERS and ERD of each stride to
a reference stride duration by means of piece-wise polynomial time-warp algorithm, similarly
to that proposed by Sadeghi and coll. [52]. Briefly, the algorithm performs a polynomial inter-
polation of the time axis against a reference period (the stride in our case). We used a third
order polynomial interpolation with a 2 s time-window centered at each velocity peak (VP) of
the swing foot. This time-window exceeded the duration of the stride and ensured that the
Subcortical control of locomotion
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border-effect did not influence the analysis window. We analyzed the STN activity (either
STN–or STN+) contralateral to each foot VP (VPcontra). A time-warp algorithm was applied
for each single stride and stride phases (i.e. single- and double-support phases of the stance,
acceleration and deceleration phases of the swing) defined according to the instants: heel con-
tact, toe off and velocity peak of the swing foot.
Network analyses
We investigated the inter-hemispheric connectivity of the two STNs by computing the spectral
coherency (Coh), the phase locking value (PLV) [53] and the amplitude cross-correlation
(CC). We selected this metric as they estimate the synchronized rhythmic excitability of neural
ensembles, which is considered useful for the flow of information between nodes of a func-
tional network as it might strengthen the information transmission [9,53,54]. The Coh repre-
sents one of the most widely accepted metric of functional connectivity [9]. The PLV and the
CC disentangle the two main components of the Coh, respectively the phase and the amplitude
correlation of the investigated signals [53,55].
We divided resting, standing and walking recordings in multiple epochs of 3 s and com-
puted all the following interaction metrics in each epoch and averaged across epochs for each
subject separately. For spectral coherence, we used multi-tapers spectral profiles computed
over 13 frequency bins (2 up to 90 Hz) defined to minimize the overlaps and with constant rel-
ative bandwidth equal to 0.5.
Coherency is defined as:
CohðX;YÞ ¼
Sxy
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SxxSyy
p







 ð4Þ
where Sxx, Syy represent the auto-spectrum of signal X and Y, respectively and Sxy represents
the cross-spectrum. This measure (i.e. Coh) is dependent from both phase and amplitude,
which were further separately measured. We band-pass filtered the (artefact free) LFPs with 13
Fig 1. Spectral profiles (average) during resting, upright standing, and gait. Average spectral power of the STN
local field potential during resting (blue line), standing (pink line) and gait (green line) for the two hemispheres, with
less (–) and more (+) striatal dopamine innervation. Results are corrected for the nominal noise floor level of the
device (150nV/rtHz, [32,33]), all values above 0dB/Hz are reliable. Shaded areas represent the confidence intervals (5–
95%) of the group mean. The peak at 32 Hz is a known artefact of the Activa PC+S1 system tied to clock settings or
due to a triggered check of the battery status.
https://doi.org/10.1371/journal.pone.0198691.g001
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finite impulse response (FIR) filters with central frequencies 2 up to 90 Hz and with constant
relative bandwidth of 0.5. The band-pass filtered data were then Hilbert transformed to extract
the analytic signal
X^ðtÞ ¼ HðXðtÞÞ: ð5Þ
The PLV is defined as:
PLV ðX;YÞ ¼
1
N
XN
i
ejDφi










ð6Þ
where Δφi represents the phase difference between X and Y at the i-th time sample. The PLV
describes the phase of the signals, being independent from their amplitude, and it helps under-
standing the Coh, especially when the signal-to-noise ratio of the recording is questioned [55].
We then computed the correlation of the signals amplitude with the CC analysis. To quan-
tify CC between amplitudes
Xa ¼ jX^ j ð7Þ
of signal X and Y we used the Pearson correlation coefficient (r) defined as:
rðX;YÞ ¼
1
N
XN
i
Xa   mXa
sXa
Ya   mYa
sYa
ð8Þ
where (μ) represent the sample mean and (s) the sample standard deviation.
All three connectivity measures range from 0 to 1, meaning “no” or “complete” coherence,
phase synchrony or CC, respectively. For these measures, we quantified surrogate noise levels
by time-rotation of the original time series. Specifically, under the null-hypothesis of no corre-
lation between signals x and y, we split-and-rotate the time course of y at random onsets and
quantified all three connectivity metrics on the time-rotated y against the original signal of x.
We repeated this procedure 100 times, assessing the distribution of the null-hypothesis. For
each of the three metrics separately, we computed the p-value as the number of elements from
the surrogate distribution that exceeded the observed measure. We considered only significant
values (p<0.05) for further statistical analyses. As for power modulation analyses, we quanti-
fied the group level variance using similar bootstrapping approach. We compared all possible
combinations (i.e. rest vs. walking, standing vs. walking, rest vs. standing) for all the computed
indices by means of the Wilcoxon test matched pairs. Of relevant note, we were not able to
compare inter-hemispheric connectivity by gait phases because of the overlay between the two
hemibodies (i.e. the single-support phase of one leg is the swing phase of the other leg, and
vice versa).
We instead investigated the correlation between inter-hemispheric connectivity and striatal
dopaminergic denervation. To this end, we estimated the overall striatal dopaminergic loss,
which was calculated as the mean of the dopaminergic loss of left and right striatum. However,
this measure prevented the distinction between hemispheres (as for PSD), only illustrating the
overall dopaminergic loss of each subject. To overcome this limitation, we also correlated the
PLV with the AI (Eq 2) as a measure for the dopaminergic degeneration imbalance between
the two hemispheres.
All methods and analyses were implemented in Matlab (Matlab 2013a, The MathWorks,
Inc., Natick, Massachusetts, USA) using ad hoc algorithms, fieldtrip [56] and integrated in
Brainstorm [57]. Due to strict privacy laws, the datasets and analyses of this study shall be
made available only upon personal request.
Subcortical control of locomotion
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Results
Clinical data
Before surgery (pre-DBS), the median UPDRS-III score in meds-off condition was 44 points
(range: 26–55) and 11 points (range: 4–24) in meds-on condition. After surgery (post-DBS),
the median UPDRS-III score in meds-off and stim-off condition was 42 points (range: 27–65),
in stim-on (and meds-off) condition was 15 points (range: 9–31), in meds-on (and stim-off)
was 12 points (range: 8–23), and in meds-on and stim-on condition was 10 points (range:
5–16). The median percentage of improvement (see formula in Patients and surgery section)
due to dopaminergic medication was 76.79% (range: 42.50–92.73%) and the one related to
STN-DBS was 66.56% (range: 52.50–83.64%). Complete demographic and clinical information
of each subject are listed in Table 1.
Biomechanical data
In agreement with previous studies, subjects with PD showed shortened stride length and
lower stride velocities (both average and maximum velocity) with respect to matched healthy
subjects [41,58]. Of note, the duration of the stance and double-support phase (as percentage
of the stride) was within the normal range, thus suggesting that despite the disease-related bio-
mechanical alterations, the patients preserved a normal timing of the gait cycle (i.e. no shuf-
fling gait or festination) (Table 2).
SPECT data
As expected, all PD patients showed significantly reduced non-displaceable binding potential
(BPND) of DAT in the caudate nucleus and the putamen. The striatal dopaminergic loss
exceeded 50% bilaterally in six out of eight subjects (Table 3). The clinically most affected side
(higher UPDRS-III scores) always corresponded to the striatum with less nigro-striatal dopa-
minergic innervation. The most dopamine-depleted hemisphere was the right one in three
subjects.
Table 1. Clinical data.
Subject Age
(years)
Disease duration
(years)
LEDD
(mg)
UPDRS-III
(score)
Pre-DBS Post-DBS Pre-DBS Post-DBS
Meds-off Meds-on Meds-off stim-off Meds-off
stim-on
Meds-on stim-off Meds-on stim-on
wue03 61 18 2725 600 40 9 45 17 23 14
wue09 55 19 1200 730 50 11 33 16 8 11
wue04 54 7 658 400 26 8 27 5 9 8
wue02 65 10 1100 800 40 23 39 19 17 16
wue10 56 10 1200 550 69 14 65 25 20 5
wue07 61 10 650 220 43 24 29 15 8 9
wue06 51 11 1133 180 46 11 48 12 11 6
wue11 53 11 1300 460 55 4 51 9 13 14
Patients were evaluated with the UPDRS-III within one month prior to the implants (pre-DBS) after overnight (>12 h) suspension of all dopaminergic drugs (meds-off)
and upon receiving 1 to 1.5-times (range 200–300 mg) the levodopa-equivalent of the morning dose (meds-on). After surgery (post-DBS), patients were also assessed
with the UPDRS-III in four conditions: (i) stimulation off for at least two hours (stim-off); (ii) bilateral STN stimulation (stim-on); (iii) meds-on (as pre-DBS); (iv)
meds-on and stim-on. Wue11 is the only female patient. DBS, deep brain stimulation; LEDD, levodopa equivalent daily dose; STN, subthalamic nucleus; UPDRS-III,
Unified Parkinson Disease Rating.
https://doi.org/10.1371/journal.pone.0198691.t001
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Local subthalamic oscillations
We did not find any clear modulation of local STN activity when comparing the power profiles
of walking and standing with resting state (Fig 1). The STN activity was also not modulated
during specific gait phases (Fig 2). The STN neuronal oscillations were not related to the stria-
tal dopamine content, despite the wide range of DAT binding loss (46–86%) in our patient
Table 2. Anthropometric and kinematic data.
Subject and group wue03 wue09 wue04 wue02 wue10 wue07 wue06 wue11 PD HC
Body height (cm) 180.55 181.92 170.99 176.16 187.43 175.45 167.17 166.72 175.80±7.32 174.24±6.47
Inter-ASIS distance (mm) 284.63 287.64 236.48 329.34 273.9 238.92 252.84 260.74 270.56±30.54 290.07±34.74
Foot length (mm) 266.1 255.05 260.94 272.13 268.41 240.92 238.53 250.82 256.61±12.52 254.11±15.22
Limb length (mm) 935.36 936.8 892.24 854.05 938.24 915.47 875.85 863.11 901.39±34.65 900.43±29.62
Weight (Kg) 93.95 100.58 71.91 107.49 98.35 77.49 67.52 101.5 89.85±15.23 76.54±10.74
BMI (Kg/m2) 28.82 30.39 24.6 34.64 28 25.17 24.16 36.52 29.04±4.61 25.22±3.58
Stride duration (s) 1.18±0.05 1.08±0.03 1.23±0.03 1.18±0.02 1.16±0.04 1.09±0.04 1.1±0.04 1.18±0.04 1.15±0.05 1.13±0.09
Stance duration (%stride) 62.38±1.95 64.11
±1.65
63.93±1.16 65.11±1.61 63.66±1.57 59.31±2.07 60.52
±1.37
65.55±1.57 63.07±2.19 62.31±1.62
Double-support duration (%
stride)
24.11±1.97 28.24
±2.59
27.97±1.69 30.55±1.75 27.07±2.22 18.22±3.41 21.22
±1.94
31.03±2.48 26.05±4.52 24.58±3.32
Stride length (%BH) 52.23
±0.04
62.03
±0.06
61.99±0.03 72.38±0.04 66.12±0.07 53.32±0.06 64.56
±0.09
54.58±0.05 60.90±7.04 72.00±6.41
Stride average velocity (%BH/
s)
44.26±0.05 52.57
±0.05
50.40±0.04 65.80±0.06 60.66±0.05 49.37±0.07 55.65
±0.07
46.26±0.05 53.12±7.28 64.17±9.37
Stride max velocity (%BH/s) 147.59
±0.25
165.61
±0.7
163.17
±0.13
195.01
±0.15
181.25
±0.19
166.56
±0.20
187.8
±0.20
151.75
±0.13
169.84
±16.83
199.63
±21.44
Stance and double-support duration are expressed as the percentage of the duration of the stride (i.e. the interval between two subsequent heel strikes of the same foot).
The stride length and the stride average velocity were calculated as a percentage of the body height (BH) of each subject. Data are shown as mean ± standard deviation.
 p<0.05
Steel-Dwass all pairs. ASIS = anterior-superior iliac spines; BMI = body mass index; HC = healthy control group; PD = Parkinson’s disease patient group.
https://doi.org/10.1371/journal.pone.0198691.t002
Table 3. Non-displaceable binding potentials of dopamine reuptake transporters.
Subject and group Caudate nucleus left Putamen left Striatum left Caudate nucleus right Putamen right Striatum right Asymmetry index STN–
wue03 0.49 0.31 0.40 0.31 0.28 0.30 28.57 R
wue09 0.72 0.48 0.61 0.62 0.37 0.49 21.82 R
wue04 1.15 0.70 0.93 0.58 0.44 0.50 60.14 R
wue02 0.88 0.57 0.72 1.43 0.91 1.17 47.62 L
wue10 0.97 0.50 0.75 1.20 0.74 0.96 24.56 L
wue07 0.92 0.64 0.76 1.22 0.79 1.00 27.27 L
wue06 1.31 0.59 0.95 1.56 0.91 1.20 23.26 L
wue11 1.15 0.79 0.96 1.41 0.74 1.05 8.96 L
PD 0.95±0.26 0.57±0.15 0.76±0.19 1.04±0.47 0.65±0.25 0.83±0.35 30.27±16.09
HC 2.57±0.57 2.30±0.42 2.33±0.48 2.62±0.52 2.23±0.48 2.30±0.48 2.57±2.14
The BPND of DAT in the striatum was used to identify the hemisphere with less (i.e. STN–, bold) or more (i.e. STN+) dopaminergic innervation. For healthy subjects,
we considered the average striatal binding of left and right, which did not significantly differ. Data are shown as mean ± standard deviation.
 p<0.05
Steel-Dwass all pairs. BPND, non-displaceable binding potential; DAT, dopamine reuptake transporter; HC = healthy control group; PD = Parkinson’s disease patient
group; STN = subthalamic nucleus.
https://doi.org/10.1371/journal.pone.0198691.t003
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collective (Fig 3). Still, the STN+ showed an increase of the average β-band power during walk-
ing, which did not reach a statistical significance (Fig 1). The lack of a clear pattern was partic-
ularly evident when looking at each STN independently. We showed a bilateral reduction of
the β-activity during walking in five STNs (of four subjects: wue09 STN–, wue10 STN–, wue07
STN–and STN+, wue03 STN+), whereas five STNs (of four subjects: wue04 STN–and STN+,
wue10 STN+, wue6 STN+ and wue11 STN+) showed an increase of the β-power (Fig 3).
Inter-hemispheric subthalamic coupling
We showed a reduction in the inter-hemispheric subthalamic coupling during walking with
respect to the upright standing and resting state condition. In particular, the phase synchroni-
zation (PLV) of the two STNs diminished significantly in the β-frequency band (Fig 4). We
did not find any correlation between the PLV values and the overall striatal dopaminergic loss
(resting: ρ: 0.47, p = 0.24; standing: ρ: 0.19, p = 0.65; walking: ρ: 0.05, p = 0.90) or the AI (rest-
ing: ρ: -0.61, p = 0.1; standing: ρ: 0.32, p = 0.44; walking: ρ: 0.35, p = 0.40).
Fig 2. Modulation of the spectral power during the gait cycle. Event related synchronization (ERS) and desynchronization
(ERD) in low β- (top) high β- (middle) and γ-frequency band (bottom). Subthalamic power changes of the phases of gait are
shown as the average relative change of the whole stride of all subjects. Shaded areas represent the confidence intervals (5–
95%) of the group mean. We analyzed the power changes of STN–and STN+ during the gait cycle of the contralateral foot
(but they could be also referred to the matched gait phases of the ipsilateral one). Stance is the period during which the foot is
on the ground (dark and light orange bars). The stance phase includes a period of bilateral foot contact with the floor
(double-support phases [dark orange bars]), and a period of unilateral foot contact (single-support phase [light orange bar]).
The swing phase (light green and dark green bars) is the interval in which the foot is lifted from the floor. Thanks to the
velocity peak (VP) of the marker placed on the lateral malleolus, we identified an acceleration (light green) a deceleration
(dark green) sub-phase of the swing phase. HS = heel strike; TO = toe off; VP = velocity peak; lower case subscript indicates
the foot contralateral (contra) or ipsilateral (ipsi) to STN–or STN+.
https://doi.org/10.1371/journal.pone.0198691.g002
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Fig 3. Spectral profiles (single subject) during resting, upright standing and gait. Single subject spectral power of the STN local field potential during
resting (blue line), standing (pink line) and gait for the two hemispheres, with less (–) and more (+) striatal dopamine innervation. Axial slices are left-
right flipped to match the corresponding STN. The peak at 32 Hz is a known artefact of the Activa PC+S1 system tied to clock settings or due to a
triggered check of the battery status. SPECT scans (central column) show striatal dopaminergic loss as percentage decline with respect to healthy subjects
(calculated from BPND of DAT, Table 3).
https://doi.org/10.1371/journal.pone.0198691.g003
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Discussion
In this study, we showed in PD patients an inter-hemispheric subthalamic coupling in the β-
frequency band during resting and standing, and a desynchronization during gait (Fig 4).
The framework of human locomotion control starts in the SMA, reaches the basal ganglia
for refinement and then the MLR, where the cerebellar inputs converge, to descend to the
medullary and pontine reticular formations and the spinal cord [59]. The STN is a cornerstone
of this network, receiving direct afferences from the SMA and projecting to both the MLR and
the basal ganglia output nuclei (i.e. the GPi and the SNr), which also project to the MLR [15].
The STN modulates the integration of cortical and cerebellar information by activating or
inhibiting the MLR via direct glutamatergic projection or basal ganglia GABAergic output
[59]. These feed-forward pathways can support the information processing in the MLR and the
medial reticular formation (i.e. rhythm generating system)[59], which projects to the CPGs in
the spinal cord.
We suggest that subthalamic inter-hemispheric desynchronization may reflect the down-
stream conveying of locomotor information for each body side separately, which may facilitate
the spontaneous alternating activity of the spinal CPGs for steady linear walking. Of relevance,
the movement-related modulation of the subthalamic coupling was narrowed to the β-fre-
quency band (Fig 4). This result further supports the relevance of β oscillations in motor con-
trol. The functional circuits of the brain are multiple and segregated by frequency, so that the
Fig 4. Inter-hemispheric coherence. Inter-hemispheric coherence (Coh, top panel), phase locking value (PLV, bottom
left plot) and amplitude cross-correlation (CC, bottom right plot) during resting state (blue line), upright standing (pink
line) and walking (green line). Statistical significance (red bar, paired Wilcoxon test, p<0.05 uncorrected) was reached
for the PLV selectively in the β-frequency band between resting state and walking. Shaded areas represent the confidence
intervals (5–95%) of the group mean.
https://doi.org/10.1371/journal.pone.0198691.g004
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precise tuning to distinct frequencies could provide a way of marking and segregating different
motor networks, over and above any anatomical segregation of processing streams [60].
Besides this physiological interpretation, we cannot exclude that the changes in subthalamic
dynamics during gait in PD may be compensatory or maladaptive. The lack of correlation
between the PLV and the overall striatal dopaminergic loss and the AI argues against this inter-
pretation. However, it is well known that in the untreated state, PD is dominated by patholog-
ically exaggerated synchronization and coherence in the basal ganglia-cortical circuit, which
implies a shift from a dynamic system to stability [17,38,61–67]. Therefore, the subthalamic
inter-hemispheric desynchronization during gait, with respect to resting and standing, might
also reflect a need to compensate for an excessive static connectivity (persistent β-coupling) of
the motor network.
Overall, these findings are of particular interest considering the evolution of stimulation
therapy towards (adaptive) closed-loop systems directly triggered by biological signals [29]. By
timing the stimulation bursts to the phase of tremor oscillations, Cagnan and coll. showed that
phase-specific stimulation could control tremor severity in subjects with essential tremor and
dystonia [68]. In this study, the stimulation was triggered by kinematic measurements of
tremor, but the trigger could be easily extended to recordings of the LFP, using the strength of
different oscillators to determine the stimulation phase in real-time [68]. During the develop-
ment of such an applicable closed-loop stimulation, besides identifying reliable markers of a
pathological brain activity it would be crucial to characterize the activity patterns of common
and frequent motor behaviors (e.g. gait) [29]. Our study represents the first step in this
direction.
Much of the interpretation of our findings presently remains speculative, given also the
absolute novelty of our recordings. A subthalamic inter-hemispheric network has been consis-
tently described and investigated in subjects with PD [19,22–25], but only during resting state
or simple unilateral movements. In particular, voluntary movements modulate the subthala-
mic coupling in the θ- and α-frequency bands, but not in the β-frequency band [19,30]. This
led to the hypothesis that the subthalamic coherence in the β-frequency band in PD could
directly reflect a striatal dopamine loss [19], but its inconsistent suppression by levodopa chal-
lenges this idea [23]. Alternatively, inter-hemispheric synchronization and desynchronization
in the β-frequency band may serve selectively complex and bilateral motor control processing
[60], such as locomotion.
A secondary finding of our study is the inter-hemispheric subthalamic coupling during
resting, which likely reflect polysynaptic inter-hemispheric neural interactions [22]. This result
is in line with previous studies in PD [19,22–25] and complements the inter-hemispheric corti-
cal coupling [64,69] and cortico-subthalamic coupling [64,70] in defying a long-distance syn-
chronization network (β-network) in PD [22]. A number of anatomical connections may
contribute to such a network, including (i) bilateral cortical inputs and synchronization via the
corpus callosum [64,69–71] of the hyperdirect [72] or the direct pathways [15], (ii) bilateral pro-
jections of the striatum to both STNs [73], and (iii) subthalamic connections through the GPi/
SNr and the MLR [23].
In contrast to network activity, we did not find a clear modulation of local subthalamic
activity (i.e. PSD) during walking or standing with respect to resting state (Fig 1). This (unex-
pected) result is, however, in line with two previous studies that also failed to show a clear sup-
pression of the β-band power in the STN of 15 PD patients during walking [49,74]. The lack of
β-suppression in the STN during walking may be due to the small β-activity recorded in the
recruited patients (Fig 3) and to the technical limitations of the recording device, which
showed a poor signal-to-noise ratio. However, we have corrected our analysis for the nominal
noise level of the device by normalizing each PSD to 150 muV/Hz [32,33] and we were able to
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capture with the same device a clear subthalamic β-suppression during upper-arm movements
in three patients of the current sample (i.e. wue02, wue09, and wue11) [19]. It seems therefore
unlikely that the lack of consistent β-suppression relies on device limitations. Instead, it should
be considered that in this study we did not assess the subthalamic β-activity during transition
phases (i.e. when changing an ongoing motor action, such as at gait initiation or termination),
and the subthalamic β-activity signaled the likelihood of a forthcoming motor or cognitive
action [75–77]. Therefore, the sensorimotor systems in PD could maintain a status quo (lack of
β-suppression) during standing and unperturbed walking as steady state motor actions.
The mismatch between local and network activity, and the lack of a correlation with striatal
dopamine loss (Fig 3), might explain the difficulties in ameliorating gait disturbances with
STN-DBS as well as the poor levodopa responsiveness of some of these symptoms [78].
Despite these negative findings, we would like to report an anecdotal subthalamic β-sup-
pression during the swing phase of the gait cycle (Fig 2, epochs between TO and HS [ipsi- and
contralateral]). This β-suppression was limited to the STN, thus possibly reflecting the striatal
dopamine influence of movement control [19].
This study has several limitations. Firstly, without histological verification the placement of
the electrodes in STN remains presumptive. Secondly, although our analytical techniques are
biased against the detection of stochastic, non-oscillatory activity, we cannot exclude having
captured such oscillations (that characterize the ventro-medial area of the STN) in our analy-
sis. Still, we verified the electrode location by fusing the pre- and post-operative imaging of
each subject and we recorded from the chronically-active electrodes, which were effective in
improving motor symptoms (Table 1). Furthermore, none of the patients reported stimula-
tion-induced behavioral or mood changes related to ventral STN stimulation, thus indirectly
confirming that we recorded the activity of the dorsolateral part of the STN, the area with pre-
dominant oscillatory activity [79–82]. Thirdly, the subthalamic coherence can be due to the
volume conduction of a synchronous activity from a third source (e.g. the cerebral cortex).
Measurements of coherence are indeed susceptible to zero-phase volume conduction effects;
however, this should not be the case for inter-hemispheric interactions. Previous studies dem-
onstrated that the extent of the volume conduction effect depends on several issues such as the
source density, the orientation, and the conducting media [83]. This led to a wide range of pos-
sible distances (from 0.6 to 5 mm) at which volume conduction may occur [83], but all below
the distance between the two STNs. The distance across STNs saved our recordings from the
common input of the background magnetic field (i.e. volume conduction), but did not prevent
the possible interference from a third (unknown) source of oscillations, which might influence
the synchronization analysis. Although the STN afferents are mainly ipsilateral, studies in rats
have identified a few thalamic and peduncolopontine axons that also projected to the contra-
lateral STN [84,85].
Despite these limitations, it is worth mentioning that we recorded the LFPs months after
surgery and with a fully implanted device, thus limiting the influence of the high impedance
variability and the microlesioning effect that bias the immediate post-operative recordings
[70].
In summary, this study highlights the inter-hemispheric subthalamic desynchronization in
the β-frequency band during walking in subjects with PD. This result has a twofold bearing.
First, it expands our understanding of locomotor control in subjects with PD. This topic is of
particular relevance given the high incidence of gait disturbances in these patients and the
related consequences (i.e. falls, fractures, institutionalization, loss of independence, and
increased mortality) [86]. Second, this study suggests that in some cases (i.e. gait), the brain
signals, which could allow feedback-controlled stimulation techniques, might derive from an
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inter-hemispheric network activity rather than local oscillations (e.g. single STN beta-band
activity) [74].
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